GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (NSE:ALPA) » Definitions » Cyclically Adjusted PB Ratio

Alpa Laboratories (NSE:ALPA) Cyclically Adjusted PB Ratio : (As of May. 26, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Alpa Laboratories Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Alpa Laboratories Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Alpa Laboratories's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpa Laboratories Cyclically Adjusted PB Ratio Chart

Alpa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.80

Alpa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.80 - 1.12 -

Competitive Comparison of Alpa Laboratories's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpa Laboratories's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's Cyclically Adjusted PB Ratio falls into.



Alpa Laboratories Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Alpa Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Alpa Laboratories's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/152.9243*152.9243
=0.000

Current CPI (Dec. 2023) = 152.9243.

Alpa Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201203 46.495 76.889 92.474
201206 0.000 79.567 0.000
201209 0.000 82.244 0.000
201212 0.000 83.774 0.000
201303 44.419 85.687 79.274
201306 0.000 88.365 0.000
201309 42.546 91.042 71.465
201312 0.000 91.425 0.000
201403 41.969 91.425 70.201
201406 0.000 94.103 0.000
201409 40.343 96.780 63.747
201412 0.000 96.780 0.000
201503 41.139 97.163 64.749
201506 0.000 99.841 0.000
201509 46.303 101.753 69.588
201603 43.825 102.518 65.373
201703 45.022 105.196 65.449
201803 46.362 109.786 64.579
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 46.812 118.202 60.563
201906 0.000 120.880 0.000
201909 47.481 123.175 58.949
201912 0.000 126.235 0.000
202003 47.704 124.705 58.499
202006 0.000 127.000 0.000
202009 50.341 130.118 59.165
202012 0.000 130.889 0.000
202103 51.159 131.771 59.372
202106 0.000 134.084 0.000
202109 56.947 135.847 64.106
202112 0.000 138.161 0.000
202203 57.855 138.822 63.732
202206 0.000 142.347 0.000
202209 54.049 144.661 57.136
202212 0.000 145.763 0.000
202303 63.961 146.865 66.600
202306 0.000 150.280 0.000
202309 68.115 151.492 68.759
202312 0.000 152.924 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Alpa Laboratories  (NSE:ALPA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Alpa Laboratories Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Alpa Laboratories's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpa Laboratories (NSE:ALPA) Business Description

Traded in Other Exchanges
Address
33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the business segment of Drugs and Chemicals. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.